Mifepristone Drugmaker: Louisiana Has Not Demonstrated Standing In REMS Dispute
NEW ORLEANS — The generic manufacturer of mifepristone, one of two drugs used to induce early termination of pregnancy, argues to the Fifth Circuit U.S. Court of Appeals that a case,...To view the full article, register now.
Already a subscriber? Click here to view full article